Bipartisan team in Congress looks to expand insurance coverage for ovarian cancer screening
Slotkin is leading the bill and described her family’s experience with ovarian cancer and insurance as motivation for her work.

SOURCE CHECK
TAP FOR WHYThe Hill is an established national news outlet, and the site's rating across 151 stories supports a strong credibility assessment. This report identifies its author and includes direct comments from two lawmakers, though it offers limited independent sourcing.
- Source type — Established national news outlet.
- Track record — The site's rating across 151 stories is 79, indicating a substantial history of assessed coverage.
- Author attribution — The report names its author.
- Source diversity — Includes direct comments from two bipartisan sponsors but little independent or opposing sourcing.
The report clearly describes the bill's goals and quotes two lawmakers from different parties. It provides limited independent context and does not include critics or outside experts.
HOW WE SCORE ↗The story includes supportive views from Democratic and Republican sponsors, but it gives no opposing perspective or independent assessment of the proposal.
- Source diversity — Quotes two sponsors from different parties but no outside sources or critics.
- Counterarguments presented — No objections or counterarguments are included.
- Loaded language — The report is generally neutral in its wording.
- Opinion vs reporting — Written as a news report rather than an opinion piece.
The article uses largely matter-of-fact language and presents supportive comments from sponsors on both sides of the aisle. Slotkin’s criticism of Republicans is clearly attributed and included as past context.
- Language tone — Mostly descriptive language without overt partisan framing.
- Source selection — Quotes bipartisan sponsors, though it does not include critics or independent sources.
- Framing — Focuses on the proposed coverage and education provisions.
- Omission — Does not discuss potential objections, but this alone does not establish a partisan lean.
Sens. Elissa Slotkin and Katie Britt are leading a bipartisan bill to expand insurance coverage for genetic testing and increase education about gynecologic cancer risk. Reps. Rosa DeLauro and Don Bacon are also backing the legislation.
The Ovarian Cancer IMPACT Act, led by Sens. Elissa Slotkin and Katie Britt, would require insurance plans to cover genetic testing for patients with hereditary risk factors and expand education and outreach about gynecologic cancer risk. Reps. Rosa DeLauro and Don Bacon are also backing the bill.
The bill would also reauthorize Johanna’s Law, a CDC program that funds a federal education campaign about gynecologic cancers. Slotkin cited her mother’s ovarian cancer and her family’s insurance difficulties as motivations for her work on the issue; Slotkin and Britt described the proposal’s goals in comments to The Hill.
Community verdict
13 VOTESPeople in this story
SWIPE →House counterpart on the legislation
President criticized by Slotkin in a prior speech about healthcare
House counterpart on the legislation
Part of a bigger story
3 OUTLETSSlotkin and Britt are backing a bipartisan Senate bill to improve ovarian cancer prevention, testing and care. Center outlets present the bill as an effort to expand prevention, testing and care; an opinion column instead argues its insurance mandate would spread genetic-testing costs across policyholders.
- ARTICLES
- 3
- OUTLETS
- 3
- AVG CRED
- 77
Discussion · 0
Loading comments…




